IMPF wants the panel to see if the provisions for government use in Indian Patent Act can be invoked to facilitate the generic availability of medicines used for the treatment of breast cancer.
The two medicines prescribed together is a standard treatment regimen approved in over 100 countries for both early and metastatic HER2-positive breast cancer.
Niramai, a Bengaluru-based startup founded by Geetha Manjunath, a healthcare industry veteran, has developed a technology that can help detect cancer using thermal analytics and A.I.
